Abstract
BackgroundTNFi drug survival is one of the valid outcome measure in rheumatological diseases. TNFi drug survival is not evaluated adequetly in non-radiographic axial spondyloarthritis (nr-axSpA).ObjectivesObjective of this study was to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have